Tuesday, May 26th, 2015 9:00AM PST

Intelligent NGS Assay Design: Oncomine™ Focus Assay for NGS clinical research in oncology

Next-generation sequencing (NGS) is changing the landscape of clinical research. This powerful technology is enabling researchers to move from running many sequential tests to a single workflow that provides DNA and RNA results across many genes with the detection of relevant SNPs, CNVs, gene fusions and indels.

Learn how our NGS experts are impacting research today and gain valuable insights into their assay design process.

We will cover the following:
  • Overview of Oncomine™ Assay products
  • Oncomine™ Assay design approach
  • Performance and results


Featured Speakers

image Seth Sadis, PhD
Director of Oncology, Research & Development, Thermo Fisher Scientific

81 Wyman Street Waltham, MA 02454 | 800.678.5599

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
LabRoots, Inc · 18340 Yorba Linda Boulevard · Yorba Linda, CA 92886 · USA